AI screening tool for breast cancer genetic risk
Part of Cancer, Skin clinical trials.
This trial tests an AI tool that predicts genetic risk for breast cancer. It may help women identified as high-risk by their breast surgeon get quicker genetic counseling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older.
- A breast surgeon has identified you as having a high genetic risk for breast cancer.
- You have been referred to a genetic counselor or geneticist for further evaluation.
- You agree to join and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This trial is testing an AI tool that analyzes your tumor tissue to help doctors choose the best treatment before surgery for triple negative breast cancer. It is for people who plan to have chemo or other drugs before their operation.
This study uses an artificial intelligence (AI) model to analyze breast MRI images (non-contrast) to help detect breast cancer earlier. It's looking at whether the AI can find signs of cancer without needing a contrast dye injection.
This study tests whether artificial intelligence (AI) can help radiologists read mammograms (breast X-rays) more accurately during routine breast cancer screening. It aims to see if AI can catch more cancers early while reducing unnecessary follow-up exams.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.